V CompBrief BY VELARION

Chief Operating and Business Officer · LB PHARMACEUTICALS INC (LBRX)

Gad Soffer

FY2025 is the first fiscal year CompBrief holds for Gad Soffer as a named executive officer of LB PHARMACEUTICALS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$3,808,637

2nd of 3 named executive officers at LB Pharmaceuticals by FY2025 total.

3 named officers on file for LB PHARMACEUTICALS, FY2025

See an example →

What this number hides

The filing gives the total. LB PHARMACEUTICALS’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how LB PHARMACEUTICALS’s whole pay program stands against its peers

  • LB PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LBRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2026 (DEF 14A).

Free

Get Gad Soffer’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Gad Soffer and every company like it: Velarion Intel, free for 3 days, no card →

Gad Soffer compensation by year

LB PHARMACEUTICALS Summary Compensation Table · the one fiscal year held
In US dollars, as LB PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$402,292
Bonus$194,150
Option awards$3,200,445
All other$11,750
Total$3,808,637

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LB PHARMACEUTICALS INC DEF 14A filed April 23, 2026, accession 0001193125-26-173679, and prior-year filings. Open the filing on EDGAR.

How this page was built: the LB PHARMACEUTICALS INC filed document, accession 0001193125-26-173679. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option229,860—$15.00
Option26,893—$15.00

Per the Outstanding Equity Awards at Fiscal Year-End table in LB PHARMACEUTICALS INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

LB PHARMACEUTICALS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Heather TurnerChief Executive Officer$11,884,985
Gad Soffer · this pageChief Operating and Business Officer$3,808,637
Anna EramoChief Medical Officer$2,376,939

Gad Soffer's compensation dossier, LB PHARMACEUTICALS

You have read Gad Soffer's totals and holdings. The dossier adds each equity grant LB PHARMACEUTICALS disclosed for Gad Soffer and LB PHARMACEUTICALS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full LB PHARMACEUTICALS compensation record

free company brief
LB PHARMACEUTICALS INC (LBRX) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within LB PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order LB PHARMACEUTICALS's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are LB PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order LBRX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Gad Soffer's compensation dossier